Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

In vitro activity of antiseptic solutions against Madurella mycetomatis: implications for eumycetoma management.

Eadie K, Fahal A, van de Sande WW.

Br J Dermatol. 2015 Jun;172(6):1657-9. doi: 10.1111/bjd.13570. Epub 2015 Apr 29. No abstract available.

PMID:
25429729
2.

Double-stranded RNA mycovirus infection of Aspergillus fumigatus is not dependent on the genetic make-up of the host.

Refos JM, Vonk AG, Eadie K, Lo-Ten-Foe JR, Verbrugh HA, van Diepeningen AD, van de Sande WW.

PLoS One. 2013 Oct 22;8(10):e77381. doi: 10.1371/journal.pone.0077381. eCollection 2013.

3.

Best practice in early psychosis intervention for Australian indigenous communities: indigenous worker consultation and service model description.

Catts S, O'Toole B, Neil A, Harris M, Frost A, Eadie K, Evans R, Crissman B, McClay J, Shorey T.

Australas Psychiatry. 2013 Jun;21(3):249-53. doi: 10.1177/1039856213480532. Epub 2013 Apr 24.

PMID:
23616378
4.

Communicating in the pre-hospital emergency environment.

Eadie K, Carlyon MJ, Stephens J, Wilson MD.

Aust Health Rev. 2013 May;37(2):140-6. doi: 10.1071/AH12155.

PMID:
23452407
5.

A randomised, feasibility trial of a tele-health intervention for acute coronary syndrome patients with depression ('MoodCare'): study protocol.

O'Neil A, Hawkes AL, Chan B, Sanderson K, Forbes A, Hollingsworth B, Atherton J, Hare DL, Jelinek M, Eadie K, Taylor CB, Oldenburg B.

BMC Cardiovasc Disord. 2011 Feb 25;11:8. doi: 10.1186/1471-2261-11-8.

6.

Clinical indicators for routine use in the evaluation of early psychosis intervention: development, training support and inter-rater reliability.

Catts SV, Frost AD, O'Toole BI, Carr VJ, Lewin T, Neil AL, Harris MG, Evans RW, Crissman BR, Eadie K.

Aust N Z J Psychiatry. 2011 Jan;45(1):63-75. doi: 10.3109/00048674.2010.524621. Epub 2010 Oct 26.

PMID:
20977312
7.

Is a national framework for implementing early psychosis services necessary? Results of a survey of Australian mental health service directors.

Catts SV, Evans RW, O'Toole BI, Carr VJ, Lewin T, Neil AL, Harris MG, Frost AD, Crissman BR, Eadie K.

Early Interv Psychiatry. 2010 Feb;4(1):25-30. doi: 10.1111/j.1751-7893.2009.00157.x.

PMID:
20199477
8.

Appraising evidence for intervention effectiveness in early psychosis: conceptual framework and review of evaluation approaches.

Catts SV, O'Toole BI, Carr VJ, Lewin T, Neil A, Harris MG, Frost AD, Crissman BR, Eadie K, Evans RW.

Aust N Z J Psychiatry. 2010 Mar;44(3):195-219. doi: 10.3109/00048670903487167. Review.

PMID:
20180724
9.

MAPKAPK-2 signaling is critical for cutaneous wound healing.

Thuraisingam T, Xu YZ, Eadie K, Heravi M, Guiot MC, Greemberg R, Gaestel M, Radzioch D.

J Invest Dermatol. 2010 Jan;130(1):278-86. doi: 10.1038/jid.2009.209. Epub .

10.

Randomised controlled trial of a secondary prevention program for myocardial infarction patients ('ProActive Heart'): study protocol. Secondary prevention program for myocardial infarction patients.

Hawkes AL, Atherton J, Taylor CB, Scuffham P, Eadie K, Miller NH, Oldenburg B.

BMC Cardiovasc Disord. 2009 May 9;9:16. doi: 10.1186/1471-2261-9-16.

11.

Device-independent, real-time identification of bacterial pathogens with a metal oxide-based olfactory sensor.

Bruins M, Bos A, Petit PL, Eadie K, Rog A, Bos R, van Ramshorst GH, van Belkum A.

Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):775-80. doi: 10.1007/s10096-009-0700-1. Epub 2009 Feb 4.

12.

RespiFinder: a new multiparameter test to differentially identify fifteen respiratory viruses.

Reijans M, Dingemans G, Klaassen CH, Meis JF, Keijdener J, Mulders B, Eadie K, van Leeuwen W, van Belkum A, Horrevorts AM, Simons G.

J Clin Microbiol. 2008 Apr;46(4):1232-40. doi: 10.1128/JCM.02294-07. Epub 2008 Feb 6.

13.

High-throughput amplification fragment length polymorphism (htAFLP) analysis identifies genetic lineage markers but not complement phenotype-specific markers in Moraxella catarrhalis.

Hays JP, Gorkink R, Simons G, Peeters JK, Eadie K, Verduin CM, Verbrugh H, van Belkum A.

Clin Microbiol Infect. 2007 Jan;13(1):55-62.

14.

Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.

Hays JP, van Selm S, Hoogenboezem T, Estev√£o S, Eadie K, van Veelen P, Tommassen J, van Belkum A, Hermans PW.

J Bacteriol. 2005 Dec;187(23):7977-84.

15.

Direct detection of human Staphylococcus aureus carriage in the nose using the Lightcycler Staphylococcus kit.

Choudhurry RS, Melles DC, Eadie K, Vos M, Wertheim HF, Verbrugh HA, van Belkum A, van Leeuwen WB.

J Microbiol Methods. 2006 May;65(2):354-6. Epub 2005 Sep 27.

PMID:
16194577
16.

A novel plasmid (pEMCJH03) isolated from moraxella catarrhalis possibly useful as a cloning and expression vector within this species.

Hays JP, Eadie K, Verduin CM, Verbrugh H, van Belkum A.

Plasmid. 2005 May;53(3):263-8. Epub 2004 Dec 22.

PMID:
15848230
17.

Pneumococcal vaccination does not affect the genetic diversity of Moraxella catarrhalis isolates in children.

Hays JP, Eadie K, Veenhoven R, Verduin CM, Verbrugh H, van Belkum A.

Eur J Clin Microbiol Infect Dis. 2004 Oct;23(10):801-3. No abstract available.

PMID:
15449099
18.

A new high-throughput AFLP approach for identification of new genetic polymorphism in the genome of the clonal microorganism Mycobacterium tuberculosis.

van den Braak N, Simons G, Gorkink R, Reijans M, Eadie K, Kremers K, van Soolingen D, Savelkoul P, Verbrugh H, van Belkum A.

J Microbiol Methods. 2004 Jan;56(1):49-62.

PMID:
14706750
19.

Changes in genetic types and population dynamics of Moraxella catarrhalis in hospitalized children are not associated with an exacerbation of existing disease.

Hays JP, Eadie K, Verduin CM, Hazelzet J, Verbrugh H, van Belkum A.

J Med Microbiol. 2003 Sep;52(Pt 9):815-20.

PMID:
12909660
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk